Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 826434, 7 pages
http://dx.doi.org/10.1155/2010/826434
Research Article

Promoter Variant of PIK3C3 Is Associated with Autoimmunity against Ro and Sm Epitopes in African-American Lupus Patients

1Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, 5841 S. Maryland Ave. MC 0930, Chicago, IL 60637, USA
2Section of Rheumatology, Rush University Medical Center, Chicago, IL 60612, USA
3Section of Genetic Medicine, University of Chicago, Chicago, IL 60637, USA

Received 15 January 2010; Revised 7 May 2010; Accepted 24 May 2010

Academic Editor: Brian Poole

Copyright © 2010 Silvia N. Kariuki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Harley, J. A. Kelly, and K. M. Kaufman, “Unraveling the genetics of systemic lupus erythematosus,” Springer Seminars in Immunopathology, vol. 28, no. 2, pp. 119–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Ippolito and M. Petri, “An update on mortality in systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 26, no. 5, supplement 51, pp. S72–S79, 2008. View at Google Scholar · View at Scopus
  3. C. E. Weckerle and T. B. Niewold, “The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies,” Clinical Reviews in Allergy and Immunology. Online first. View at Publisher · View at Google Scholar
  4. J. J. Hooks, H. M. Moutsopoulos, and S. A. Geis, “Immune interferon in the circulation of patients with autoimmune disease,” The New England Journal of Medicine, vol. 301, no. 1, pp. 5–8, 1979. View at Google Scholar
  5. L. E. Ronnblom, K. E. Oberg, and G. V. Alm, “Possible induction of systemic lupus erythematosus by interferon α-treatment in a patient with a malignant carcinoid tumour,” Journal of Internal Medicine, vol. 227, no. 3, pp. 207–210, 1990. View at Google Scholar · View at Scopus
  6. T. B. Niewold and W. I. Swedler, “Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C,” Clinical Rheumatology, vol. 24, no. 2, pp. 178–181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. T. B. Niewold, “Interferon alpha-induced lupus: proof of principle,” Journal of Clinical Rheumatology, vol. 14, no. 3, pp. 131–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. B. Niewold, J. Hua, T. J. A. Lehman, J. B. Harley, and M. K. Crow, “High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus,” Genes and Immunity, vol. 8, no. 6, pp. 492–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. N. Kariuki, M. K. Crow, and T. B. Niewold, “The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-α activity and low tumor necrosis factor α levels in patients with lupus,” Arthritis and Rheumatism, vol. 58, no. 9, pp. 2818–2823, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. N. Kariuki, K. A. Kirou, E. J. MacDermott, L. Barillas-Arias, M. K. Crow, and T. B. Niewold, “Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo,” Journal of Immunology, vol. 182, no. 1, pp. 34–38, 2009. View at Google Scholar · View at Scopus
  11. S. N. Kariuki and T. B. Niewold, “Genetic regulation of serum cytokines in systemic lupus erythematosus,” Translational Research, vol. 155, no. 3, pp. 109–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Lövgren, M.-L. Eloranta, B. Kastner, M. Wahren-Herlenius, G. V. Alm, and L. Rönnblom, “Induction of interferon-α by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome auto antigen—associated RNA,” Arthritis and Rheumatism, vol. 54, no. 6, pp. 1917–1927, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. S. Ramos, J. A. Kelly, C. Gray-McGuire et al., “Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus,” Genes and Immunity, vol. 7, no. 5, pp. 417–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. E. Taylor, E. F. Remmers, A. T. Lee et al., “Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus,” PLoS Genetics, vol. 4, no. 5, Article ID e1000084, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. N. Kariuki, J. G. Moore, K. A. Kirou, M. K. Crow, T. O. Utset, and T. B. Niewold, “Age- and gender-specific modulation of serum osteopontin and interferon-α by osteopontin genotype in systemic lupus erythematosus,” Genes and Immunity, vol. 10, no. 5, pp. 487–494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Salloum, B. S. Franek, S. N. Kariuki et al., “Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-α activity in lupus patients,” Arthritis and Rheumatism, vol. 62, no. 2, pp. 553–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Backer, “The regulation and function of Class III PI3Ks: novel roles for Vps34,” Biochemical Journal, vol. 410, no. 1, pp. 1–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Simonsen and S. A. Tooze, “Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes,” The Journal of Cell Biology, vol. 186, no. 6, pp. 773–782, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Stopkova, T. Saito, D. F. Papolos et al., “Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia,” Biological Psychiatry, vol. 55, no. 10, pp. 981–988, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Tang, X. Zhao, C. Fang et al., “Investigation of variants in the promoter region of PIK3C3 in schizophrenia,” Neuroscience Letters, vol. 437, no. 1, pp. 42–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Sirota, M. Firer, K. Schild et al., “Increased anti-Sm antibodies in schizophrenic patients and their families,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 17, no. 5, pp. 793–800, 1993. View at Google Scholar · View at Scopus
  22. E. M. Tan, A. S. Cohen, J. F. Fries et al., “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis and Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Google Scholar · View at Scopus
  23. J. Hua, K. Kirou, C. Lee, and M. K. Crow, “Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies,” Arthritis and Rheumatism, vol. 54, no. 6, pp. 1906–1916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. B. Niewold, T. L. Rivera, J. P. Buyon, and M. K. Crow, “Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus,” Arthritis and Rheumatism, vol. 58, no. 2, pp. 541–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. B. Niewold, S. N. Kariuki, G. A. Morgan, S. Shrestha, and L. M. Pachman, “Elevated serum interferon-α activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy,” Arthritis and Rheumatism, vol. 60, no. 6, pp. 1815–1824, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Purcell, B. Neale, K. Todd-Brown et al., “PLINK: a tool set for whole-genome association and population-based linkage analyses,” American Journal of Human Genetics, vol. 81, no. 3, pp. 559–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. E. R. Gamazon, W. Zhang, A. Konkashbaev et al., “SCAN: SNP and copy number annotation,” Bioinformatics, vol. 26, no. 2, pp. 259–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Fruci, P. Giacomini, M. R. Nicotra et al., “Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues,” Journal of Cellular Physiology, vol. 216, no. 3, pp. 742–749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Duan, R. Gao, Q. Xing et al., “A family-based association study of schizophrenia with polymorphisms at three candidate genes,” Neuroscience Letters, vol. 379, no. 1, pp. 32–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. B. Harley and J. A. James, “Epstein-Barr virus infection induces lupus autoimmunity,” Bulletin of the NYU Hospital for Joint Diseases, vol. 64, no. 1-2, pp. 45–50, 2006. View at Google Scholar · View at Scopus
  32. I. I. Gottesman and J. Shields, “A polygenic theory of schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 58, no. 1, pp. 199–205, 1967. View at Google Scholar · View at Scopus
  33. S. M. Purcell, N. R. Wray, J. L. Stone et al., “Common polygenic variation contributes to risk of schizophrenia and bipolar disorder,” Nature, vol. 460, no. 7256, pp. 748–752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. James, K. M. Kaufman, A. D. Farris, E. Taylor-Albert, T. J. A. Lehman, and J. B. Harley, “An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 3019–3026, 1997. View at Google Scholar · View at Scopus
  35. L. E. Delisi, S. B. Smith, and J. R. Hamovit, “Herpes simplex virus, cytomegalovirus and Epstein-Barr virus antibody titres in sera from schizophrenic patients,” Psychological Medicine, vol. 16, no. 4, pp. 757–763, 1986. View at Google Scholar · View at Scopus
  36. C. J. Carter, “Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii,” Schizophrenia Bulletin, vol. 35, no. 6, pp. 1163–1182, 2009. View at Google Scholar
  37. B. D. Poole, R. H. Scofield, J. B. Harley, and J. A. James, “Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus,” Autoimmunity, vol. 39, no. 1, pp. 63–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. B. D. Poole, T. Gross, S. Maier, J. B. Harley, and J. A. James, “Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments,” Journal of Autoimmunity, vol. 31, no. 4, pp. 362–371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Saito, M. R. Aghalar, and H. M. Lachman, “Analysis of PIK3C3 promoter variant in African-Americans with schizophrenia,” Schizophrenia Research, vol. 76, no. 2-3, pp. 361–362, 2005. View at Publisher · View at Google Scholar · View at Scopus